Z
Zhongyuan Yang
Researcher at Huazhong University of Science and Technology
Publications - 6
Citations - 41
Zhongyuan Yang is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Retrospective cohort study & Medicine. The author has an hindex of 2, co-authored 5 publications receiving 25 citations.
Papers
More filters
Journal ArticleDOI
Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.
Tao Chen,Zhongyuan Yang,Ashok Choudhury,Mamun Al Mahtab,Jun Li,Yu Chen,Soek Siam Tan,Tao Han,Jinhua Hu,Saeed Hamid,Lee Guan Huei,Hasmik Ghazinian,Yuemin Nan,Yogesh Chawla,Man-Fung Yuen,Harshad Devarbhavi,Akash Shukla,Zaigham Abbas,Manoj Kumar Sahu,Abdülkadir Dökmeci,Laurentias A. Lesmana,Cosmas Rinaldi A Lesmana,Shaojie Xin,Zhongping Duan,Wei Guo,Ke Ma,Zhongwei Zhang,Qiuyu Cheng,Jidong Jia,B. C. Sharma,Shiv Kumar Sarin,Qin Ning +31 more
TL;DR: The Tongji prognostic predictor model score (TPPMs), which set the number of complications as one of the determinants, showed comparable or superior ability to the Chinese Group on the Study of Severe Hepatitis B–ACLF score (COSSH-ACLFs) and MELD–sodium score (MELD–Nas) in HBV– ACLF patients, especially in cirrhotic HBV-–AClF patients.
Journal ArticleDOI
Plasma perfusion combined with plasma exchange in chronic hepatitis B-related acute-on-chronic liver failure patients
Zhongyuan Yang,Zhongwei Zhang,Qiuyu Cheng,Guang Chen,Weina Li,Ke Ma,Wei Guo,Xiaoping Luo,Tao Chen,Qin Ning +9 more
TL;DR: Evaluating the effectiveness of plasma perfusion combined with plasma exchange in patients with hepatitis B virus-related ACLF found PP’+ PE treatment significantly reversed organ failures and ameliorated the development of new organ failure and complications, thus reducing mortality risk of patients with HBV-ACLF.
Journal ArticleDOI
Establishment and validation of a prognostic model for hepatitis B virus‑related acute-on-chronic liver failure patients with bacterial infection.
Zhongwei Zhang,Zhongyuan Yang,Qiuyu Cheng,Xue Hu,Meiqi Liu,Yunhui Liu,Tingting Liu,Ke Ma,Meng Zhang,Xiaoping Luo,Tao Chen,Qin Ning +11 more
TL;DR: In this paper, the authors established and validated a nomogram for predicting 30-day mortality of hepatitis B virus-related ACLF (HBV-ACLF) patients with bacterial infection, which may facilitate optimal therapeutic strategies to improve the prognosis of these patients.
Journal ArticleDOI
Development and Validation of a Clinical Predictive Model for Bacterial Infection in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure
Zhongwei Zhang,Ke Ma,Zhongyuan Yang,Qiuyu Cheng,Xue Hu,Meiqi Liu,Yunhui Liu,Tingting Liu,Meng Zhang,Xiaoping Luo,Tao Chen,Qin Ning +11 more
TL;DR: GIC was established and validated for the prediction of bacterial infection development in HBV-ACLF, which may provide a potential auxiliary solution for the primary complication of HBV the virus-related acute-on-chronic liver failure.
Journal ArticleDOI
Proton Pump Inhibitor Therapy Increases the Risk of Spontaneous Bacterial Peritonitis in Patients with HBV-Related Acute-on-Chronic Liver Failure.
Meng Zhang,Xin Xu,Wei Liu,Zhongwei Zhang,Qiuyu Cheng,Zhongyuan Yang,Tingting Liu,Yunhui Liu,Qin Ning,Tao Chen,Junying Qi +10 more
TL;DR: In this paper, the association between proton pump inhibitor (PPI) use and spontaneous bacterial peritonitis (SBP) was investigated in patients with HBV-related acute-on-chronic liver failure (ACLF).